Christine Bent - InnovAge Holding Chief Officer
| INNV Stock | USD 4.75 0.14 2.86% |
Executive
Christine Bent is Chief Officer of InnovAge Holding Corp
| Age | 54 |
| Address | 8950 E. Lowry Boulevard, Denver, CO, United States, 80230 |
| Phone | 844 803 8745 |
| Web | https://www.innovage.com |
Christine Bent Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christine Bent against InnovAge Holding stock is an integral part of due diligence when investing in InnovAge Holding. Christine Bent insider activity provides valuable insight into whether InnovAge Holding is net buyers or sellers over its current business cycle. Note, InnovAge Holding insiders must abide by specific rules, including filing SEC forms every time they buy or sell InnovAge Holding'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christine Bent over three months ago Disposition of 10187 shares by Christine Bent of InnovAge Holding at 4.83 subject to Rule 16b-3 | ||
Christine Bent over three months ago Acquisition by Christine Bent of 86581 shares of InnovAge Holding subject to Rule 16b-3 | ||
Christine Bent over six months ago Disposition of 8734 shares by Christine Bent of InnovAge Holding at 4.0 subject to Rule 16b-3 |
InnovAge Holding Management Efficiency
The company has return on total asset (ROA) of (0.0202) % which means that it has lost $0.0202 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0603) %, meaning that it created substantial loss on money invested by shareholders. InnovAge Holding's management efficiency ratios could be used to measure how well InnovAge Holding manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.05 in 2024. Return On Capital Employed is likely to climb to -0.05 in 2024. At this time, InnovAge Holding's Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 4.6 M in 2024, whereas Total Current Assets are likely to drop slightly above 129.1 M in 2024.Similar Executives
| Found 13 records | EXECUTIVE Age | ||
| Anand Kumar | Healthcare Triangle | 50 | |
| Timothy Cruickshank | Heartbeam | 43 | |
| Michael MD | Nutex Health | 53 | |
| Amanda Hammer | Mangoceuticals, Common Stock | 38 | |
| Richa Gujarati | Heartbeam | N/A | |
| Esq JD | Nutex Health | 60 | |
| MBA FACHE | Nutex Health | N/A | |
| Kenneth Persen | Heartbeam | N/A | |
| Abhay Borwankar | Healthcare Triangle | N/A | |
| Michael Campana | Healthcare Triangle | N/A | |
| Damian David | Healthcare Triangle | N/A | |
| Yew CPA | EUDA Health Holdings | 56 | |
| Eugene Johnston | Mangoceuticals, Common Stock | 60 | |
Management Performance
| Return On Equity | -0.0603 | ||||
| Return On Asset | -0.0202 |
InnovAge Holding Corp Leadership Team
Elected by the shareholders, the InnovAge Holding's board of directors comprises two types of representatives: InnovAge Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of InnovAge. The board's role is to monitor InnovAge Holding's management team and ensure that shareholders' interests are well served. InnovAge Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, InnovAge Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Michael Scarbrough, President COO | ||
| Maria Lozzano, Chief Officer | ||
| Patrick Blair, President CEO | ||
| Robin Doerr, Chief Officer | ||
| JD Kennedy, Independent Director | ||
| Cara Babachicos, Chief Officer | ||
| RN MHA, Independent Director | ||
| Olivia Patton, Chief Officer | ||
| Rob Borella, Chief Officer | ||
| Dustin Lee, Chief Officer | ||
| Benjamin Adams, Chief Officer | ||
| Christine Bent, Chief Officer | ||
| Nicole DAmato, Chief Secretary | ||
| Barbara CPA, Chief Officer | ||
| Ryan Kubota, Director Relations | ||
| Matt Huray, Chief Officer | ||
| FACP MD, Chief Officer |
InnovAge Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is InnovAge Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0603 | ||||
| Return On Asset | -0.0202 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.02) % | ||||
| Current Valuation | 686.65 M | ||||
| Shares Outstanding | 135.46 M | ||||
| Shares Owned By Insiders | 85.03 % | ||||
| Shares Owned By Institutions | 11.90 % | ||||
| Number Of Shares Shorted | 327.93 K | ||||
| Price To Earning | 33.64 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for InnovAge Stock Analysis
When running InnovAge Holding's price analysis, check to measure InnovAge Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InnovAge Holding is operating at the current time. Most of InnovAge Holding's value examination focuses on studying past and present price action to predict the probability of InnovAge Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InnovAge Holding's price. Additionally, you may evaluate how the addition of InnovAge Holding to your portfolios can decrease your overall portfolio volatility.